181 related articles for article (PubMed ID: 33483844)
1. Impact of Dyslipidemia on the Risk of Second Cancer in Thyroid Cancer Patients: A Korean National Cohort Study.
Ho J; Kim E; Han M; Jung I; Lee J; Jo YS
Ann Surg Oncol; 2021 Aug; 28(8):4373-4384. PubMed ID: 33483844
[TBL] [Abstract][Full Text] [Related]
2. Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study.
Seo GH; Kong KA; Kim BS; Kang SY; Moon BS; Yoon HJ; Kim HO
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2580-e2588. PubMed ID: 33755732
[TBL] [Abstract][Full Text] [Related]
3. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
4. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer.
Kim HO; Lee K; Lee SM; Seo GH
JAMA Intern Med; 2020 Jan; 180(1):54-61. PubMed ID: 31633736
[TBL] [Abstract][Full Text] [Related]
5. Trends in Pediatric Thyroid Cancer Incidence, Treatment, and Clinical Course in Korea During 2004-2016: A Nationwide Population-Based Study.
Lee YA; Yun HR; Lee J; Moon H; Shin CH; Kim SG; Park YJ
Thyroid; 2021 Jun; 31(6):902-911. PubMed ID: 33107409
[No Abstract] [Full Text] [Related]
6. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
Seo GH; Cho YY; Chung JH; Kim SW
Thyroid; 2015 Aug; 25(8):927-34. PubMed ID: 26133388
[TBL] [Abstract][Full Text] [Related]
7. Impact of thyroid hormone replacement on the risk of second cancer after thyroidectomy: a Korean National Cohort Study.
Ho J; Han M; Jung I; Jo YS; Lee J
Sci Rep; 2023 Sep; 13(1):16280. PubMed ID: 37770542
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study.
Song Y; Lee HS; Park G; Kang SW; Lee JW
Front Endocrinol (Lausanne); 2022; 13():893461. PubMed ID: 35832430
[TBL] [Abstract][Full Text] [Related]
9. Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study.
Kim MS; Lee JW; Hyun MK; Song YS
Endocrinol Metab (Seoul); 2024 Apr; 39(2):288-299. PubMed ID: 38437824
[TBL] [Abstract][Full Text] [Related]
10. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
11. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
12. Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study.
Hong CM; Shin JY; Kim BI; Song HC; Yoon JK; Won KS; Kim SM; Cho IH; Jeong SY; Lee SW; Lee J
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1661-1670. PubMed ID: 34773164
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
14. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
[TBL] [Abstract][Full Text] [Related]
15. Association between obstructive sleep apnea and thyroid cancer incidence: a national health insurance data study.
Choi JH; Lee JY; Lim YC; Kim JK; Do Han K; Cho JH
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4569-4574. PubMed ID: 34032908
[TBL] [Abstract][Full Text] [Related]
16. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
Verkooijen RB; Smit JW; Romijn JA; Stokkel MP
Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748
[TBL] [Abstract][Full Text] [Related]
17. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
[TBL] [Abstract][Full Text] [Related]
18. Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study.
Lin CY; Lin CL; Huang WS; Kao CH
J Nucl Med; 2016 May; 57(5):685-90. PubMed ID: 26719377
[TBL] [Abstract][Full Text] [Related]
19. Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia.
Ho J; Kim E; Lee M; Jung I; Jo YS; Lee J
Sci Rep; 2023 Jan; 13(1):1076. PubMed ID: 36658156
[TBL] [Abstract][Full Text] [Related]
20. Thyroid carcinomas after irradiation for a first cancer during childhood.
de Vathaire F; Hardiman C; Shamsaldin A; Campbell S; Grimaud E; Hawkins M; Raquin M; Oberlin O; Diallo I; Zucker JM; Panis X; Lagrange JL; Daly-Schveitzer N; Lemerle J; Chavaudra J; Schlumberger M; Bonaïti C
Arch Intern Med; 1999 Dec 13-27; 159(22):2713-9. PubMed ID: 10597762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
